Proposal to list single use instruments supplied by Elite Brands Distribution Ltd

Hospital devices

Consultation Closed

What we’re proposing

PHARMAC is seeking feedback on a proposal to list a range of Single Use Instruments on Section H Part III of the Pharmaceutical Schedule from 1 May 2018 through a provisional agreement with Elite Brands Distribution Ltd (“Elite”).

This proposal does not require DHB hospitals to use single use instruments rather than reusable instruments.

Consultation closes at 5pm on Friday, 6 April 2018 and feedback can be emailed to procurement@pharmac.govt.nz.

What would the effect be?

This PHARMAC agreement would supersede any existing DHB contracts with this supplier for the devices proposed for listing, subject to consultation and approval by PHARMAC’s Board or delegate (“Agreement”).

The Agreement would provide national consistency for these devices as the Price and Terms and Conditions stated in the Agreement would apply to all DHB purchases from the proposed date of listing on the Pharmaceutical Schedule.

The financial impact of this agreement on DHBs would result in a national cost saving of $5000 per annum based on  usage remaining the same or similar to levels.

DHBs would be able to continue to procure other suppliers’ ranges of Single Use Instruments, as the Agreement would not be for sole supply.

DHBs would have access to educational services which would be tailored to suit the needs of the individual DHB Hospitals.

Who we think will be interested

  • DHB staff
    • Clinicians
    • Procurement Officers
  • Medical device suppliers

About single use instruments

Single use instruments are designed to be used once and then disposed of or destroyed - these are also known as disposable instruments. Some single use instruments may be used in many hospital settings such as operating theatre, emergency departments, wards and clinics.

While volumes of single use instruments are growing, usage varies in each hospital with many using a combination of single use and reusable instruments.

PHARMAC has not undertaken any work to compare the use or cost effectiveness of single use instruments with reusable instruments, and this proposal does not require hospitals to switch from reusable instruments.

Why we’re proposing this

In 2016, PHARMAC released a Request for Proposals for single use instruments. As a result, PHARMAC has listed medical devices from the following suppliers: Amtech Medical Ltd, BSN Medical Ltd, Defries Industries Ltd and Hallmark Surgical Ltd.

This provisional agreement is the fifth to arise from this process and we expect to consult on further provisional agreements, with other suppliers, over the next few months.

Details about our proposal

PHARMAC has entered into a provisional agreement with Elite for a range of single use instruments.

A full list of the products has not been included in this consultation for brevity, however we are making it available along with pricing information to appropriate DHB personnel.

The following information provides a summary of the brands and product ranges in the proposed agreement:

Brands

Number of products

Product ranges

Impact on DHBs*

Swann-Morton

43

Blades, Scalpels, Stitch cutters

$5000 p.a. saving

based on existing volumes

To provide feedback

Send us an email: procurement@pharmac.govt.nz by 5pm on Friday, 6 April 2018.

All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.

Feedback we receive is subject to the Official Information Act 1982 (OIA) and we will consider any request to have information withheld in accordance with our obligations under the OIA. Anyone providing feedback, whether on their own account or on behalf of an organisation, and whether in a personal or professional capacity, should be aware that the content of their feedback and their identity may need to be disclosed in response to an OIA request.

We are not able to treat any part of your feedback as confidential unless you specifically request that we do, and then only to the extent permissible under the OIA and other relevant laws and requirements. If you would like us to withhold any commercially sensitive, confidential proprietary, or personal information included in your submission, please clearly state this in your submission and identify the relevant sections of your submission that you would like it withheld. PHARMAC will give due consideration to any such request.